News Sentiment

ESLA sentiment intelligence

Estrella Immunopharma Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 46 Balanced news tone 42 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.84 Week of 17 Jul 2026
Weighted tone 46/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 33

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-9.4% over one week, -11.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Enterprise value to EBIT forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction -9.4% Price reacting lower
Trend fit Trend inactive -11.6% over four weeks
Fair value -53.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 31
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 33
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 12
TradingView 10
Market source 6
Stock Titan 5
simplywall.st 2
GlobeNewswire 1
Pluang 1
Minichart 1

Event Lens

What the news is about

Classified themes
Earnings 18
Market update 17
Regulatory and legal 2
Analyst action 2
Capital return 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-42 of 42
Stock Titan Direct company coverage

[NT 10-Q] Estrella Immunopharma, Inc. SEC Filing

Estrella Immunopharma, Inc. (ESLA) has filed a Form NT 10-Q, notifying the SEC of a late filing for its Quarterly Report on Form 10-Q for the period ended March 31, 2026. The company attributes the delay to administrative issues and expects to file the report within five calendar

Tone
Negative 39/100
Event
Guidance
Published
16 May 2026 04:39
Source
Stock Titan